Journal for ImmunoTherapy of Cancer

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma
Journal for ImmunoTherapy of Cancer - Tập 7 - Trang 1-14 - 2019
Indu Ramachandran, Daniel E. Lowther, Rebecca Dryer-Minnerly, Ruoxi Wang, Svetlana Fayngerts, Daniel Nunez, Gareth Betts, Natalie Bath, Alex J. Tipping, Luca Melchiori, Jean-Marc Navenot, John Glod, Crystal L. Mackall, Sandra P. D’Angelo, Dejka M. Araujo, Warren A. Chow, George D. Demetri, Mihaela Druta, Brian A. Van Tine, Stephan A. Grupp, Albiruni R. Abdul Razak, Breelyn Wilky, Malini Iyengar, Trupti Trivedi, Erin Van Winkle, Karen Chagin, Rafael Amado, Gwendolyn K. Binder, Samik Basu
Gene-modified autologous T cells expressing NY-ESO-1c259, an affinity-enhanced T-cell receptor (TCR) reactive against the NY-ESO-1-specific HLA-A*02-restricted peptide SLLMWITQC (NY-ESO-1 SPEAR T-cells; GSK 794), have demonstrated clinical activity in patients with advanced synovial sarcoma (SS). The factors contributing to gene-modified T-cell expansion and the changes within the tumor microenvir...... hiện toàn bộ
TLR9 acts as a sensor for tumor-released DNA to modulate anti-tumor immunity after chemotherapy
Journal for ImmunoTherapy of Cancer - Tập 7 - Trang 1-8 - 2019
Tae Heung Kang, Chih-Ping Mao, Young Seob Kim, Tae Woo Kim, Andrew Yang, Brandon Lam, Ssu-Hsueh Tseng, Emily Farmer, Yeong-Min Park, Chien-Fu Hung
The tumor microenvironment exists in a state of dynamic equilibrium, in which a balance of agonist and antagonist signals govern the anti-tumor immune responses. Previous studies have shown that chemotherapy could shift this balance in favor of agonistic signals for the anti-tumor immune responses mounted by CD8+ cytotoxic T lymphocytes (CTL), providing sufficiently high antigen density within the...... hiện toàn bộ
Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab
Journal for ImmunoTherapy of Cancer - Tập 5 - Trang 1-9 - 2017
Philip Friedlander, Karl Wassmann, Alan M. Christenfeld, David Fisher, Chrisann Kyi, John M. Kirkwood, Nina Bhardwaj, William K. Oh
Tremelimumab is an antibody that blocks CTLA-4 and demonstrates clinical efficacy in a subset of advanced melanoma patients. An unmet clinical need exists for blood-based response-predictive gene signatures to facilitate clinically effective and cost-efficient use of such immunotherapeutic interventions. Peripheral blood samples were collected in PAXgene® tubes from 210 treatment-naïve melanoma pa...... hiện toàn bộ
The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors
Journal for ImmunoTherapy of Cancer - Tập 7 - Trang 1-13 - 2019
Daniela Massi, Eliana Rulli, Mara Cossa, Barbara Valeri, Monica Rodolfo, Barbara Merelli, Francesco De Logu, Romina Nassini, Michele Del Vecchio, Lorenza Di Guardo, Roberta De Penni, Michele Guida, Vanna Chiarion Sileni, Anna Maria Di Giacomo, Marco Tucci, Marcella Occelli, Francesca Portelli, Viviana Vallacchi, Francesca Consoli, Pietro Quaglino, Paola Queirolo, Gianna Baroni, Fabrizio Carnevale-Schianca, Laura Cattaneo, Alessandro Minisini, Giuseppe Palmieri, Licia Rivoltini, Mario Mandalà
Clinical response to MAPK inhibitors in metastatic melanoma patients is heterogeneous for reasons still needing to be elucidated. As the patient immune activity contributes to treatment clinical benefit, the pre-existing level of immunity at tumor site may provide biomarkers of disease outcome to therapy. Here we investigated whether assessing the density and spatial tissue distribution of key imm...... hiện toàn bộ
Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
Journal for ImmunoTherapy of Cancer - Tập 2 - Trang 1-1 - 2014
Sara Labiano, Asis Palazon, Elixabet Bolaños-Mateo, Arantza Azpilicueta, Alfonso Rodriguez, Aizea Morales-Kastresana, Elena Marin, Alfonso Gurpide, Maria Rodriguez-Ruiz, M Angela Aznar, Maria Jure-Kunkel, Ignacio Melero
Uncovering a novel function of BTLA on tumor-infiltrating CD8+ T cells
Journal for ImmunoTherapy of Cancer - Tập 1 Số S1 - 2013
Cara L. Haymaker, Richard C. Wu, Krit Ritthipichai, Chantale Bernatchez, Marie-Andrée Forget, Jie Qing Chen, Hiu Liu, Ena Wang, Francesco M. Marincola, Patrick Hwu, Laszlo G. Radvanyi
Recurrent pleural effusions and cardiac tamponade as possible manifestations of pseudoprogression associated with nivolumab therapy– a report of two cases
Journal for ImmunoTherapy of Cancer - Tập 4 Số 1 - 2016
Bhaskar Kolla, Manish R. Patel
Cholangiocarcinoma cells secrete soluble factors that activate Jak/STAT signal transduction and promote MDSC expansion
Journal for ImmunoTherapy of Cancer - Tập 2 - Trang 1-1 - 2014
Jennifer Yang, Kaitlin Keenan, Thomas Mace, Matthew Ferren, Tanios Bekaii-Saab, James Fuchs, Eric Schwartz, Chenglong Li, Jiayuh Lin Pui-Kai Li, Gregory Lesinski
Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy
Journal for ImmunoTherapy of Cancer - - 2014
David J Friedman, Kristina Young, Jason R Baird, Benjamin Cottam, Talicia Savage, Pippa Newell, Melissa Kasiewicz, William Redmond, Brendan Curti, Todd Crocenzi, Michael J Gough, Marka Crittenden
The genetic landscape of the T cell non-inflamed tumor microenvironment in human solid tumors
Journal for ImmunoTherapy of Cancer - Tập 3 - Trang 1-1 - 2015
Jason J Luke, Stefani Spranger, Riyue Bao, Jorge Andrade, Thomas F Gajewski
Tổng số: 1,384   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10